TRIANA Biomedicines Appoints Mohan Bala as COO and Expands Scientific Advisory Board With Industry Experts TRIANA Biomedicines has announced a series of major leadership and scientific advisory appointments as the company continues expanding its molecular glue degrader platform and advancing…
Endospan Completes Acquisition by Artivion, Inc. After FDA Approval of the NEXUS® Aortic Arch System Endospan has announced the completion of its acquisition by Artivion in a deal that significantly strengthens Artivion’s position in the global aortic repair market and…
BAXFENDY Becomes First FDA-Approved Aldosterone Synthase Inhibitor for Adults With Hypertension in the U.S. AstraZeneca has announced that the U.S. Food and Drug Administration has approved BAXFENDY for the treatment of hypertension in adults whose blood pressure remains inadequately controlled…
Natera Receives FDA Approval for Signatera CDx as First Blood-Based MRD Companion Diagnostic in Muscle-Invasive Bladder Cancer Natera announced that the U.S. Food and Drug Administration has approved Signatera CDx as a companion diagnostic for use alongside adjuvant atezolizumab, marketed…
Kariya and NeuraLight Collaborate to Evaluate Brain Effects of Next-Generation GLP-1 Therapies Kariya Pharmaceuticals and NeuraLight have announced a strategic partnership aimed at advancing the development of next-generation brain-focused GLP-1 therapies for neurodegenerative diseases, including Parkinson’s disease and Alzheimer’s disease.…
Ionis and Biogen Report Promising Phase 2 Results for Tau-Targeting Alzheimer’s Therapy Diranersen Ionis Pharmaceuticals and Biogen have announced encouraging topline findings from the Phase 2 CELIA clinical study evaluating diranersen (IONIS-MAPTRx/BIIB080), an investigational antisense oligonucleotide (ASO) therapy designed to…
BeOne Medicines’ BEQALZI™ Receives U.S. FDA Approval as First BCL2 Inhibitor for Relapsed or Refractory Mantle Cell Lymphoma BeOne Medicines has announced that the U.S. Food and Drug Administration has granted accelerated approval to BEQALZI for the treatment of adult…
AskBio to Present New Gene Therapy and AAV Manufacturing Research at ASGCT 2026 AskBio, a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, has announced that it will present six scientific sessions at the…
Altasciences and Certara Form Strategic Partnership to Advance Model-Informed Drug Development Altasciences and Certara have announced a strategic partnership aimed at accelerating early-stage drug development through the integration of model-informed drug development technologies, biosimulation tools, and fully integrated research services.…
Rocket Pharmaceuticals Reports First Quarter 2026 Results and Advances Cardiovascular Gene Therapy Pipeline Rocket Pharmaceuticals, a commercial-stage biotechnology company focused on developing genetic therapies for rare and life-threatening disorders, has announced its financial and operational results for the first quarter…
Seek Labs Secures U.S. Patent for Innovative Isothermal Amplification Technology Designed to Advance Decentralized Molecular Diagnostics Seek Labs, a private TechBio company focused on building programmable platforms to decode, program, and resolve diseases, has announced that the United States Patent…
CareQuest Innovation Partners and PDS Health Join Forces to Expand Blood Pressure Screening in Dental Settings, Advancing Integrated Care Delivery CareQuest Innovation Partners and PDS Health have announced a new initiative aimed at expanding blood pressure screening and patient consultation…
